Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vernalis confirms death of V3381, seeks new partnerships
Pharma Times, UK
Thursday, November 18, 2010 - 8:08am
tags:
Vernalis, V3381
Sekisui to Buy Genzyme’s Test-Drug Operations For $265 Million
Bloomberg
Thursday, November 18, 2010 - 8:00am
tags:
Genzyme, M&A, Sekisui
Actelion, Eyed by Amgen, May Fetch $9.8 Billion in Takeover, Analysts Say
Bloomberg
Thursday, November 18, 2010 - 7:58am
tags:
Actelion, Amgen, M&A
Novartis efficiency drive to boost profitability
Reuters
Wednesday, November 17, 2010 - 8:44pm
tags:
Novartis, restructuring
Summary Box: Medicare advisers say $93,000 cancer drug Provenge helps patients live longer
Yahoo/AP
Wednesday, November 17, 2010 - 6:26pm
tags:
Provenge, Dendreon, vaccines, prostate cancer
Cholesterol drug could be financial boon for Merck
Yahoo/AP
Wednesday, November 17, 2010 - 6:24pm
tags:
Merck, cholesterol, Anacetrapib, Pfizer
FDA Accused Of Contempt Over Morning-After Pill
Pharmalot
Wednesday, November 17, 2010 - 1:09pm
tags:
FDA, morning-after pill, Plan B contraceptive
Cell Therapeutics’ drug moves ahead in Europe
Bizjournals.com
Wednesday, November 17, 2010 - 1:07pm
tags:
Europe, Cell Therapeutics, pixantrone, Pixuvri
No Room for RNAi in Roche's Operational Excellence Plans
InVivo
Wednesday, November 17, 2010 - 1:02pm
tags:
Roche, RNAi, Genentech, Novartis, Alnylam
Human Genome downgraded over lupus drug potential
Marketwatch
Wednesday, November 17, 2010 - 12:59pm
tags:
lupus, Benlysta, Human Genome Sciences
Resverlogix Falls on Merck's `Huge Success' With Rival Cholesterol Drug
Bloomberg
Wednesday, November 17, 2010 - 12:57pm
tags:
Merck, Resverlogix, cholesterol
ISTA Pharma's Bromday gets 3 years of exclusivity
Yahoo/AP
Wednesday, November 17, 2010 - 12:53pm
tags:
Bromday, Ista, generics
Santarus Hit by Generic Zegerid
Yahoo/Zacks.com
Wednesday, November 17, 2010 - 12:52pm
tags:
generics, Zegerid, Santarus, Par Pharmaceutical, Depomed
Avanir Announces Public Stock Offering
Seeking Alpha
Wednesday, November 17, 2010 - 12:51pm
tags:
Avanir, stock offering
K-V names permanent CEO, Hermelin to resign from board
Fierce Pharma
Wednesday, November 17, 2010 - 12:50pm
tags:
KV Pharmaceutical
Is Johnson & Johnson's Cash Flow Just For Show?
Motley Fool
Wednesday, November 17, 2010 - 12:49pm
tags:
JNJ
Why Roche’s CEO Is Wrong to Blame Obamacare for 4,800 Layoffs
BNET Pharma
Wednesday, November 17, 2010 - 12:04pm
tags:
Roche, Severin Schwan, healthcare reform, layoffs, Tamiflu
Why Nile Therapeutics May Succeed Where J&J Failed
Seeking Alpha
Wednesday, November 17, 2010 - 12:01pm
tags:
JNJ, Nile Therapeutics, Natrecor
Big Boost for Human Genome Sciences Stock Likely
Minyanville
Wednesday, November 17, 2010 - 11:47am
tags:
Benlysta, Human Genome Sciences, lupus, FDA
Actelion shares surge (again) as M&A buzz hits fever pitch
Fierce Biotech
Wednesday, November 17, 2010 - 11:46am
tags:
Actelion, M&A, Amgen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.